PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes.
In a report released today, Jason Wittes from Roth MKM reiterated a Buy rating on Alphatec Holdings (ATEC – Research Report), with a price target of $22.00. The company’s shares opened today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback